New York Life Foundation and the Cigna Foundation in partnership with E4E Relief have established the Brave of Heart Fund to support families of frontline healthcare heroes in their darkest hours.The Brave of Heart Fund provides charitable grants to eligible family members of frontline healthcare workers and volunteers who lose their lives to COVID-19. The Fund is launching with $25 million donations each from New York Life and Cigna with the goal of raising $100 million.
Donations are being accepted at BraveofHeartFund.com and current fund supporters can be found there as well. New York Life Foundation is matching gifts from individuals, dollar-for-dollar, up to $25 million. Cigna will also provide beneficiaries with behavioral and emotional health support to help them navigate issues associated with grief.
Cash grant awards will provide basic and continuing financial support for critical needs such as funeral costs, medical care, food, educational expenses, mortgage or rent payments and immediate living expenses, as these family members manage the impact of the COVID-19 crisis. Additionally, families of fallen healthcare workers who need help bearing the burden of the economic impact of losing their loved ones to COVID-19 - loss of income, funeral expenses or medical bills - are also encouraged to apply for grants at BraveofHeartFund.com beginning in May.
"When tragedy strikes, large or small, people want to help. The Brave of Heart Fund is an overwhelming example of this, with New York Life and Cigna rising to the occasion to support fallen healthcare workers. In addition to this vital effort, E4E Relief offers employers of all sizes the ability to support employees impacted by the pandemic and other catastrophic disasters."
We are grateful to our donors who have joined us to ensure that through the Brave of Heart Fund we are able to offer charitable financial support to survivor families in need. Together we are helping the families whose lives will be forever changed by pandemic and by the loss of a loved one.